Metrovacesa stock
Price history
+1.98% over the period1 year: from €11.10 (November 20, 2025) to €11.32 (November 20, 2026), +1.98%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | €11.32 |
| October 30, 2026 | €10.84 |
| September 30, 2026 | €10.28 |
| August 31, 2026 | €10.60 |
| July 31, 2026 | €11.12 |
| June 30, 2026 | €11.30 |
| May 29, 2026 | €10.58 |
| April 30, 2026 | €11.92 |
| March 31, 2026 | €11.10 |
| February 27, 2026 | €13.00 |
| January 30, 2026 | €10.40 |
| December 31, 2025 | €9.36 |
| November 28, 2025 | €11.45 |
| November 20, 2025 | €11.10 |
At a glance
The company
Real estate development company that builds and sells residential and commercial properties and land in Spain
Latest results
Quarter to September 30, 2026
Next event
Dividend
TickerLandia's take on Metrovacesa
- Pricier than similar companies: trailing 12-month P/E 29 vs 19 (+54%) in a group of 8.
- Strong point: Dividend (71/100 in its group). Weak point: Earnings stability (34/100).
- “Dividend traps” (Spain): No. 1 of 5.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−16.15% from the 52-week high
Analysts · 4 analysts
Average target€11.24−0.73% vs. price
Buy 0 · Hold 2 · Sell 2 · Sell
TickerLandia Fingerprint: Metrovacesa
Compared with similar companies: low risk, high dividend, and high price.
Financials and price compared with 32 companies in the real estate - development industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricehigh69
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 29.7 90 EV/EBITDA 11.9 34 Forward P/E 25.7 95 Price/book 1.35 70 Price/sales 1.97 58 Profitabilityaverage53
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 24.6% 36 Net margin 10.1% 42 ROE 6.4% 58 ROA 4.5% 73 Operating margin 18.5% 58 Earnings stabilitylow34
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 3.9% 52 Loss-making yearscounts in reverse: lower means more earnings stability 2 of 5 annual reports 17 Growthaverage52
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +11.16% 61 Revenue growth (year over year) +139.50% 92 Earnings growth (year over year) −215.07% 2 Financial strengthhigh69
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Debt/equitycounts in reverse: lower means more financial strength 0.30 80 Current ratio 3.28 83 Interest coverage 4.69 48 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.61 64 Dividendhigh71
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 6 years 32 Dividend yield 17.4% 90 Payout ratiopays out more than its earnings 521.2% 91 Market momentumaverage60
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +12.10% 82 Relative strength (6 months) +1.38% 58 1-year return +1.98% 40 Distance from 200-day average +2.23% 59 Risklow29
How much the price swings.
Metric Value Position in group Beta (1 year) 0.54 31 Volatility (60 days) 16.4% 8 Maximum drawdown (12 months) 23.6% 47
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Metrovacesa is pricier than similar companies
Metrovacesa's P/E (trailing 12 months): 29.0, +54% against the median of a group of 8 similar companies (18.8).
Compared with 8 similar companies
| Metric | Metrovacesa | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 29.0 | High | |
| Forward P/E | 25.4 | High | |
| ROE | 6.4% | Middle | |
| Price/book | 1.32 | Middle |
Grey band: the middle half of the group; tick: the median; dot: Metrovacesa. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€317.38M
Latest quarter · Q2 2026
Net income
€17.84M
Latest quarter · Q2 2026
Quarterly net margin
5.6%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- €1.72B
- P/E
- 29.0
- EPS
- €0.39
- Volume
- 203.81K
- Daily trading
- €2.26M
- Dividend yield
- 17.84%
How Metrovacesa is changing
All resultsRevenue grew 38.3% a year on average over the last 5 years
Revenue has grown for 5 fiscal years in a row
Profitable in 3 of 5 fiscal years
Returns
Metrovacesa returns with dividends
€1,000 invested in Metrovacesa 5 years ago, on November 22, 2021, would be worth €2,918 today with dividends reinvested: +191.79% in total, +23.92% per year. On price alone it would be €1,480 (+47.97%).
| Period | Metrovacesa | IBEX 35 | €1,000 becomes |
|---|---|---|---|
| 1 month | +8.43% | −1.15% | €1,084 |
| 6 months | +5.99% | +4.55% | €1,060 |
| Year to date | +20.94% | +9.04% | €1,209 |
| 1 year | +24.49% | +18.04% | €1,245 |
| 3 years | +97.49% | +91.82% | €1,975 |
| 5 years | +191.79% | +113.95% | €2,918 |
| 10 years | −29.25% | +92.39% | €708 |
Over the last 6 months it has done better than 47% of the stocks in the Finance sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. IBEX 35: price only. Calculate your investment
The chart in detail
Metrovacesa: technical analysis
Metrovacesa shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 30.6% below its all-time closing high (€16.31, May 16, 2018).
- Trend
- No clear trend
- RSI (14 sessions)
- 52
- Between 30 and 70
- vs 200-session average
- +2.23%
Support and resistance
Price areas where Metrovacesa has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance€11.64+2.80%3 touches, last on July 22, 2026
- Resistance€11.47+1.33%2 touches, last on October 22, 2026
- Last price€11.32
- Support€10.84−4.24%2 touches, last on August 26, 2026
- Support€10.47−7.55%4 touches, last on September 21, 2026
- Support€10.27−9.32%2 touches, last on October 20, 2026
Volatility and risk
Over the last year it has moved less than the IBEX 35.
- Beta (1 year) vs IBEX 35
- 0.54
- Volatility (60 sessions, annualised)
- 16.4%
- Largest fall in the last year
- −23.62%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Metrovacesa: seasonality
Average monthly price change over 12 years
Over the last 12 years, the strongest month for Metrovacesa has been December: +17.36% on average, positive in 3 years out of 11. The weakest has been March: −4.50% on average, positive in 6 years out of 12. November, the current month, has been positive in 5 years out of 10 (+0.57% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +5.34% | +1.81% | 7 of 11 |
| February | +1.94% | −0.32% | 5 of 11 |
| March | −4.50% | +0.06% | 6 of 12 |
| April | −0.25% | +2.00% | 7 of 12 |
| May | −4.02% | −5.13% | 4 of 12 |
| June | +1.58% | −0.47% | 4 of 11 |
| July | −1.65% | −1.59% | 4 of 11 |
| August | −2.61% | +0.24% | 6 of 11 |
| September | +3.99% | −2.42% | 5 of 11 |
| October | +0.52% | +2.44% | 6 of 11 |
| November | +0.57% | −0.37% | 5 of 10 |
| December | +17.36% | −2.60% | 3 of 11 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Metrovacesa and its competitors
Spain is the market where Metrovacesa S.A. concentrates its activity, and its customers include buyers of residential and commercial premises as well as parties interested in land. The company develops and sells residential and commercial premises and also sells land, so its business spans property built for sale and plots of ground. Both lines are carried out in Spain, where the company has operated since it was founded in 1918.
- Headquarters
- Madrid, Spain
- Employees
- 210
- Founded
- 1918
- Chief executive
- Jorge de Leza Eguiguren
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| MetrovacesaMVC | $1.89B | 6.4% | 29.0 | +5.99% |
| Neinor HomesHOME | $1.96B | 12.8% | 14.0 | +13.68% |
| Dom DevelopmentDOM | $1.58B | 34.5% | 9.01 | −2.92% |
| Atrium LjungbergATRLJ.B | $1.32B | 2.1% | 22.5 | −27.82% |
| LAMDA DevelopmentLAMDA | $1.08B | -6.4% | — | −6.00% |
| DeveliaDVL | $992.53M | 27.7% | 7.76 | −14.97% |
Same industry or related industries, similar size. Compare Metrovacesa with its competitors · Full profile
